Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Keybanc Maintains Overweight on Talos Energy, Raises Price Target to $21
Keybanc maintains Talos Energy (NYSE:TALO) with a Overweight and raises the price target from $19 to $21.
Recap: Talos Energy Q4 Earnings
Talos Energy (NYSE:TALO) reported its Q4 earnings results on Thursday, February 24, 2022 at 05:30 PM.
Here's what investors need to know about the announcement.
Talos Energy Q4 EPS $0.45 Beats $0.15 Estimate, Sales $382.95M Beat $296.14M Estimate; Sees FY22 Production 60M-64M Barrels Of Oil/Day
Talos Energy (NYSE:TALO) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.15 by 200 percent. This is a 209.76 percent increase over losses of $(0.41) per share from the same
Talos Energy, EnLink Midstream Announce Complete Carbon Capture, Transportation And Sequestration Services Solution
Talos Energy Inc. (NYSE:TALO) ("Talos" or the "Company") and EnLink Midstream, LLC (NYSE:ENLC) ("EnLink") announced today that they have executed a memorandum of understanding to
Talos Energy Q3 Adj. EPS $(0.04) Beats $(0.07) Estimate, Sales $290.91M Beat $267.15M Estimate
Talos Energy (NYSE:TALO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 92.31 percent increase over losses of $(0.52) per share from the
